Management

Robert W. Cook was appointed President and CEO in August 2012. Mr. Cook was previously Chief Financial Officer and Senior Vice President, Finance and Administration since April 2004. Prior to joining us, Mr. Cook was Vice President, Finance and Chief Financial Officer of Pharmos Corporation since January 1998 and became Executive Vice President of Pharmos in February 2001. From May 1995 until his appointment as Pharmos's Chief Financial Officer, he was a vice president in GE Capital's commercial finance subsidiary, based in New York. From 1977 until 1995, Mr. Cook held a variety of corporate finance and capital markets positions at The Chase Manhattan Bank, both in the United States and in several overseas locations. He was named a managing director of Chase and several of its affiliates in January 1986. Mr. Cook received his B.S. in International Finance from The American University, Washington, D.C.

Dr. Stephane Allard has been Chief Medical Officer since March 2007. Prior to joining EpiCept in 2007 Dr. Allard was Chief Executive Officer, President, and a Director of Biovest International. Prior to joining Biovest, Dr. Allard was Vice President of Medical Affairs of the US affiliate of Sanofi-Synthelabo, a multi-billion dollar global pharmaceutical company and was responsible for the medical strategy of products such as Plavixâ, Ambienâ, Avaproâ, and Eloxatinâ. Dr. Allard served as President of Synthelabo, Inc. and Director of Research and Development at Lorex Pharmaceuticals, where he was responsible for the development of Ambienâ and the start up of Synthelabo, Inc in the US. He led the clinical activities for products such as Ambienâ, Kerloneâ and Uroxatralâ and the liaison efforts with the FDA. He served as European Clinical Director of Clinical Research for Synthelabo (Paris). Dr. Allard received his medical doctorate from Rouen Medical College and received a Diplomate of CESAM (Certificate of Statistical Studies Applied to Medicine) and a PhD in Clinical Pharmacology and Pharmacokinetics (Pitie Salpetriere Hosp.); Paris, France.

Charles Darder has been our Corporate Controller since January 2007. Prior to joining us, Mr. Darder was the Director of Finance for Bradley Pharmaceuticals since May 2006. Prior to that Mr. Darder was with Memory Pharmaceuticals since May 2000 in various finance positions. From 1993 until 2000, Mr. Darder held a variety of corporate finance positions at The Prudential, Con Edison and The McGraw-Hill Companies. Mr. Darder received his B.S. in Public Accounting from Pace University, Pleasantville, NY and is a Certified Public Accountant.